ENTITY
SMARTSCORE: 2.2/5

Cytomx Therapeutics (CTMX US)

3
Analysis
Health CareUnited States
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company. The Company focuses on developing probody therapeutics for the treatment of cancer. CytomX Therapeutics serves pharmaceutical industries throughout the United States.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x